Replies to post #66239 on Blue Diamond Ventures Inc (BLDV)

[Ronin_Trader]

Sterling thanks for the clarification, and the added DD notes you mention in your post about the Funder, and about the Funder verifying step 6 with Health Canada.

Big things coming!! Hold on peeps!

[mikeski74]

Thanks for clearing that up Stervc

[Walker]

GREAT POST - and exactly what I was thinking. The funding is to gain access to the massive project that AMS is undergoing. AMS will then become a fully owned sub of BLDV and we will reap all of the rewards.

[Walker]

MUST READ POST - AMS And BLDV are going to be huge. Now add in the huge Israel component and connections, and ELtron, and Cannabis Clean, etc and we have a Monster MJ company here and growing very fast.

[JPS02]

Amazing and massive post stervc, mods please sticky this post!

Thanks for the deep insight stervc.

[tazinu]

Why would AMS become owned by BLDV if BLDV isn't in the funding equation? If AMS gets funded on its own what use does it have for BLDV besides some technology from Israel connections.

[Kool Aid Man]

Explain what "step 6" means. How big a hurdle is that? IMO it seems pretty massive because it means the facility has to be completely built out and operational.

Here are the new rules as of May. "There are currently 44 licensed producers in Canada plus 187 applications at the review stage."

https://www.newcannabisventures.com/health-canada-streamlines-medical-cannabis-production-licensing-process/

[JPS02]

stervc, I think the following paragraph in your post is very powerful and insightful, therefore I broke up each sentence to better understand each of the important points you are presenting:

stervc's post: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132570308

1. AMS will pay the Funder back the $12 million plus interest from the Revenues to be generated.

2. AMS already have relationships with pharmaceutical companies as clientele in place to support their marijuana cultivation in Canada whom will buy product and products from AMS.

3. They also have huge plans for expansion in place.

4. After a year and since the AMS project is expected to be fully operational by then, AMS is then expected to exercise its right to refinance its operations by using their completed facility as collateral to remove the current Funder from the equation.

5. They will pay the Funder back its money with interest then AMS will become their own Funder by funding its own operations.

These important points that you present beg the question of the value of AMS to BLDV once the:

i) $12 million financing is approved;

ii) Health Canada approval to cultivate is received;

iii) Revenues start to be earned from cultivation operations; and,

iv) Expansion is completed in the future.

I think this question is important in regards to the positive impact on the BLDV pps given the non-dilutive acquisition of AMS that you pointed out in this post:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132347362

Thanks for sharing your insightful thoughts.

Go BLDV!

[GreenKnight]

Awesome post! Thanks for that!

[JPS02]

stervc, I think the following paragraph in your post is very powerful and insightful, therefore I broke up each sentence to better understand each of the important points you are presenting:

stervc's post: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132570308

1. AMS will pay the Funder back the $12 million plus interest from the Revenues to be generated.

2. AMS already have relationships with pharmaceutical companies as clientele in place to support their marijuana cultivation in Canada whom will buy product and products from AMS.

3. They also have huge plans for expansion in place.

4. After a year and since the AMS project is expected to be fully operational by then, AMS is then expected to exercise its right to refinance its operations by using their completed facility as collateral to remove the current Funder from the equation.

5. They will pay the Funder back its money with interest then AMS will become their own Funder by funding its own operations.

These important points that you present beg the question of the value of AMS to BLDV once the:

i) $12 million financing is approved;

ii) Health Canada approval to cultivate is received;

iii) Revenues start to be earned from cultivation operations; and,

iv) Expansion is completed in the future.

I think this question is important in regards to the positive impact on the BLDV pps given the non-dilutive acquisition of AMS that you pointed out in this post:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132347362

Thanks for sharing your insightful thoughts.

Go BLDV!